Spruce Biosciences, Inc. (SPRB) Total liabilities 2022–2025
Spruce Biosciences, Inc. (SPRB) total liabilities at each fiscal year-end, per SEC filings.
$10.5MFY2025 · since FY2022: $17.2M → $10.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $10.5M | -35.9% |
| FY2024 | $16.4M | -40.3% |
| FY2023 | $27.4M | +59.9% |
| FY2022 | $17.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More SPRB financial trends
SPRB RevenueSPRB Net incomeSPRB Net marginSPRB Gross profitSPRB Gross marginSPRB Operating incomeSPRB Operating marginSPRB Operating cash flowSPRB Free cash flowSPRB Capital expendituresSPRB Return on equitySPRB Stock buybacksSPRB Dividends paidSPRB Total assetsSPRB Shareholders’ equitySPRB overview →